Skin Channel
Related Channels


Desoximetasone is a medicine licensed to relieve the symptoms of eczema, dermatitis, psoriasis, and many other skin conditions. As a type of steroid, it works by reducing inflammation and suppressing an overactive immune system. It comes in the form of an ointment, a cream, a gel, or a spray, and is applied on the affected skin areas twice daily. Potential side effects include burning, itching, and dryness.

What Is Desoximetasone?

Desoximetasone (Topicort®) is a prescription skin medication. It comes in the form of an ointment, gel, cream, or spray. It belongs to a group of medications known as topical steroids and is used to treat inflammation and itching due to a wide variety of skin conditions, such as eczema, psoriasis, dermatitis, and allergic reactions. The spray is approved only for the treatment of plaque psoriasis.
(Click What Is Desoximetasone Used For? for more information on this topic, including possible off-label uses.)

Are There Side Effects?

Just like any medicine, desoximetasone may cause side effects. However, not everyone who uses the drug will experience problems. In fact, most people tolerate it quite well.
If reactions do occur, in most cases, they are minor and either require no treatment or are treated easily by you or your healthcare provider. Serious side effects are less common.
Common side effects of desoximetasone include but are not limited to:
  • Burning
  • Irritation
  • Itching
  • Dryness.
(Click Desoximetasone Side Effects to learn more, including potentially serious side effects you should report immediately to your healthcare provider.)

Desoximetasone Medication Information

Referring Pages:
Terms of Use
Advertise with Us
Contact Us
About eMedTV
Privacy Policy
Copyright © 2006-2020 Clinaero, Inc.
eMedTV serves only as an informational resource. This site does not dispense medical advice or advice of any kind. Site users seeking medical advice about their specific situation should consult with their own physician. Click Terms of Use for more information.